A. Koutsoukou (Athens, Greece), R. A. Floto (Cambridge, United Kingdom)
Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review
K. Hnin, C. Nguyen, K. Carson, B. Smith (Adelaide, Australia)
|   |
Patterns of antibiotic prescribing for pneumonia at the outpatient to inpatient transition
E. Van de Garde, S. Natsch, P. Van der Linden (Nieuwegein/Utrecht, Utrecht, Nijmegen, Netherlands)
| |
Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
H. C. Chang, A. Omar, S. Swift, A. C. Vandal, G. Liu, P. Kyme, C. Wong (Auckland, New Zealand; Los Angeles, United States Of America)
| |
Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis)
M. Patout, C. Fercocq, A. Alanio, S. Touratier, E. Raffoux, F. Derouin, J.M. Molina, S. Bretagne, P. Ribaud, A. Bergeron (Paris, France)
| |
Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
M. Fernandes, T. Gatheral, R. Dhunnookchand, D. Bilton, R. Wilson, M. Loebinger (London, United Kingdom)
| |
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised
M. Carrabba, A. Colombo, M. Zarantonello, A. Maraschini, G. Fabio (Milano, Italy)
| |
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
E. Hagiwara, Y. Suido, A. Nakazawa, A. Sekine, H. Kitamura, T. Baba, T. Shinohara, R. Nishihira, S. Komatsu, T. Kato, T. Ogura (Yokohama, Japan)
| |
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
E. Makarova, N. Menkov, M. Czapaeva, G. Varvarina (Nizhny Novgorod, Russian Federation)
| |
Bactericidal activity of ciprofloxacin dry powder for inhalation (DPI) in a hollow fiber (HF) model
S. Obertegger, G. Weskott, P. Surdakowski, K. Merfort, M. Glenschek-Sieberth (Wuppertal, Germany)
| |
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy
S. Abreu, I. Silveira, J. P. Ferreira, S. Rocha, P. Leuschner, J. Correia (Porto, Portugal)
| |
Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
P. Van der Linden, S. Natsch, E. Van de Garde (Hilversum/Blaricum, Utrecht, Nijmegen, Netherlands)
| |
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality
L. Pisani, L. Fasano, A. Koutelou, S. Ambretti, V. Ribuffo, F. Natali, S. Tedeschi, F. Tumietto, S. Nava (Bologna, Italy)
| |
Efficacy of ciprofloxacin against resistant mucoid or non-mucoid P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics after ciprofloxacin DPI treatment
S. Obertegger, G. Weskott, P. Surdakowski, M. Glenschek-Sieberth (Wuppertal, Germany)
| |
Effect of long term azithromycin on exacerbations in non CF bronchiectasis
M. Naeem, K. Nourain, R. Reddy (Kettering, United Kingdom)
| |
Beta lactam plus macrolide antibiotic combination therapy reduces the mortality of community-acquired pneumococcal pneumonia more than beta lactam antibiotics alone
A. Ito, T. Ishida, H. Tachibana, A. Nishiyama, K. Furuta, M. Tanaka, F. Tokioka, H. Yoshioka, M. Arita, T. Hashimoto (Kurashiki, Japan)
| |
Investigation of gram positive antibiotics as aerosol administration (cubicin, vancomycin, zyvoxid)
I. Kioumis, P. Zarogoulidis, S. Lampaki, J. Organtzis, L. Yarmus, J. F. Turner, K. Zarogoulidis, G. Pitsiou, A. Pataka, R. Browning (Thessaloniki, Baltimore, Greece; Las Vegas, Bethesda, United States Of America)
| |
Extended-spectrum-beta-lactamase producing multidrug resistant nosocomial bacterial isolates causing lower respiratory tract infection in Tertiary Care Hospital, Nepal
M. K. Sah, R. K. Shrestha, S. K. Mishra, J. B. Sherchand, B. Rijal, B. M. Pokharel (Kathmandu, Nepal)
| |
Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections
W. Yang, B. He (Beijing, China)
| |